Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Department of Neurology, Philipps-Universität Marburg, Marburg, Germany.
Mov Disord. 2021 Jan;36(1):230-235. doi: 10.1002/mds.28260. Epub 2020 Sep 10.
Isolated rapid eye movement sleep behavior disorder is known to be prodromal for alpha-synucleinopathies, such as Parkinson's disease (PD) and dementia with Lewy bodies. The [ F]fluorodeoxyglucose-positron emission tomography (PET)-based PD-related brain pattern can be used to monitor disease progression.
We longitudinally investigated PD-related brain pattern expression changes in 20 subjects with isolated rapid eye movement sleep behavior disorder to investigate whether this may be a suitable technique to study prodromal PD progression in these patients and to identify potential phenoconverters.
Subjects underwent two [ F]fluorodeoxyglucose-PET brain scans ~3.7 years apart, along with baseline and repeated motor, cognitive, and olfactory testing within roughly the same time frame.
At baseline, 8 of 20 (40%) subjects significantly expressed the PD-related brain pattern (with z scores above the receiver operating characteristic-determined threshold). At follow-up, six additional subjects exhibited significant PD-related brain pattern expression (70% in total). PD-related brain pattern expression increased in all subjects (P = 0.00008). Four subjects (20%), all with significant baseline PD-related brain pattern expression, phenoconverted to clinical PD.
Suprathreshold PD-related brain pattern expression and greater score rate of change may signify greater shorter-term risk for phenoconversion. Our results support the use of serial PD-related brain pattern expression measurements as a prodromal PD progression biomarker in patients with isolated rapid eye movement sleep behavior disorder. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
孤立性快动眼睡眠行为障碍已知是α-突触核蛋白病(如帕金森病 [PD] 和路易体痴呆)的前驱期。基于氟脱氧葡萄糖的正电子发射断层扫描(PET)可用于监测疾病进展。
我们对 20 例孤立性快动眼睡眠行为障碍患者进行了 PD 相关脑模式的纵向研究,以探讨其是否可作为研究这些患者前驱期 PD 进展的合适技术,并识别潜在的表型转化者。
受试者在大约相同的时间范围内,间隔约 3.7 年进行两次氟脱氧葡萄糖-PET 脑部扫描,并在基线和重复进行运动、认知和嗅觉测试。
基线时,20 例受试者中有 8 例(40%)显著表达 PD 相关脑模式(z 评分高于接受者操作特征确定的阈值)。随访时,另外 6 例受试者表现出显著的 PD 相关脑模式表达(总共占 70%)。所有受试者的 PD 相关脑模式表达均增加(P = 0.00008)。4 例受试者(20%)全部具有显著的基线 PD 相关脑模式表达,表型转化为临床 PD。
超阈值 PD 相关脑模式表达和更大的评分变化率可能意味着表型转化的风险更高。我们的研究结果支持使用连续 PD 相关脑模式表达测量作为孤立性快动眼睡眠行为障碍患者的前驱期 PD 进展生物标志物。© 2020 作者。运动障碍由 Wiley 期刊公司代表国际帕金森病和运动障碍学会出版。